NAV
₹37.0061
as of 16 Jun 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +5.98%
- 3Y
- +22.78%
- 5Y
- +15.12%
- Since Inception
- +13.32%
SIP returns (XIRR)
- 1Y
- +10.16%
- 3Y
- +13.89%
- 5Y
- +16.95%
- Since Inception
- +17.55%
Performance Comparison
Thinking about Tata India Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseTata Mutual Fund
CategorySectoral / Thematic
Launch Date28 Dec 2015
AMFI Code135810
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadCurrent load structure(w.e.f.18/04/2016): Exit Load: 1% if redeemed on or before expiry of 365 days from the date of allotment. Exit load for investment will be as applicable as on the date of allotment / date of registration in case of SIP and STP
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 30 Apr 2026
portfolio shared with Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Holding% NAV
- 1Sun Pharmaceutical Industries Ltd9.87%
- 2Divi Laboratories Ltd5.92%
- 3Healthcare Global Enterprises Ltd5.45%
- 4Abbott India Ltd5.37%
- 5Max Healthcare Institute Ltd5.17%
- 6Cipla Ltd5.07%
- 7Rainbow Childrens Medicare Ltd4.23%
- 8Apollo Hospitals Enterprise Ltd4.06%
- 9Mankind Pharma Ltd3.73%
- 10Dr Reddys Laboratories Ltd3.73%
Rows per page· 36 total
Page 1/4
Investment Objective
Tata India Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations